ArticleThe oncologist2025

Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series.

Ian Nykaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.